臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"kao j h"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 626-650 / 1534 (共62頁)
<< < 21 22 23 24 25 26 27 28 29 30 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2021-06-25T08:10:15Z	Real-world effectiveness and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in Taiwan	Liu C.-H.; Liu C.-J.; Su T.-H.; Yang H.-C.; CHUN-MING HONG; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-06-25T08:10:15Z	Sofosbuvir-based Interferon-Free Direct Acting Antiviral Regimens for Heart Transplant Recipients with Chronic Hepatitis C Virus Infection	Liu C.-H.; Chen Y.-S.; Wang S.-S.; Liu C.-J.; Su T.-H.; Yang H.-C.; CHUN-MING HONG; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-06-25T08:10:15Z	A noninvasive diagnosis of hepatic fibrosis by BioFibroScore® in chronic hepatitis C patients	Liu C.-H.; Liu C.-J.; CHUN-MING HONG; Su T.-H.; Yang H.-C.; Chen K.-M.; Huang Y.-P.; Yeh Y.-M.; Tien H.-L.; Liu Y.-C.; Kao J.-H.; Chen D.-S.; Chen P.-J.
臺大學術典藏	2021-06-25T08:10:14Z	Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study	Liu C.-H.; Huang Y.-J.; Yang S.-S.; Chang C.-H.; Yang S.-S.; Sun H.-Y.; Liu C.-J.; Liu W.-C.; Su T.-H.; Yang H.-C.; CHUN-MING HONG; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; Kao J.-H.
臺大學術典藏	2021-06-25T08:10:14Z	Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection	Liu C.-H.; Sun H.-Y.; Liu C.-J.; Sheng W.-H.; Hsieh S.-M.; Lo Y.-C.; Liu W.-C.; Su T.-H.; Yang H.-C.; CHUN-MING HONG; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; Kao J.-H.
臺大學術典藏	2021-06-25T08:10:13Z	Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection	Liu C.-H.; Su T.-H.; Liu C.-J.; CHUN-MING HONG; Yang H.-C.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-06-25T08:10:13Z	Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan	Liu C.-H.; Liu C.-J.; Su T.-H.; Yang H.-C.; CHUN-MING HONG; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-06-25T08:10:13Z	NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging	Su T.-H.; Liao S.-H.; CHUN-MING HONG; Liu C.-J.; Tseng T.-C.; Liu C.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chen C.-L.; Adhoute X.; Bourlière M.; Kao J.-H.
臺大學術典藏	2021-06-25T08:10:12Z	Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world data	CHUN-MING HONG; Liu C.-H.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen Y.-W.; Kao J.-H.; Liu C.-J.
臺大學術典藏	2021-06-25T08:10:12Z	High Level of Hepatitis B Core–Related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load	Tseng T.-C.; Liu C.-J.; Hsu C.-Y.; CHUN-MING HONG; Su T.-H.; Yang W.-T.; Chen C.-L.; Yang H.-C.; Huang Y.-T.; Fang-Tzu Kuo S.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-06-25T08:10:11Z	Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load	Tseng T.-C.; Liu C.-J.; Yang W.-T.; Hsu C.-Y.; CHUN-MING HONG; Su T.-H.; Tsai C.-H.; Chen C.-L.; Yang H.-C.; Liu C.-H.; Chen H.-H.; Chen P.-J.; Kao J.-H.
臺大學術典藏	2021-06-24T07:17:14Z	Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy	Sheng W.-H.; Kao J.-H.; Chen P.-J.; LI-MIN HUANG; Chang S.-Y.; Sun H.-Y.; Hung C.-C.; Chen M.-Y.; Chang S.-C.
臺大學術典藏	2021-06-15T03:12:29Z	Acute pancreatitis complicated by infarction of the spleen and spinal cord	SHU-CHEN WEI; Kao J.-H.; Lee W.-Y.; Lin J.-T.; Wang T.-H.
臺大學術典藏	2021-06-15T03:12:12Z	Reduced Toll-like receptor 3 expression in chronic hepatitis B patients and its restoration by interferon therapy	Huang Y.-W.; Lin S.-C.; SHU-CHEN WEI; Hu J.-T.; Chang H.-Y.; Huang S.-H.; Chen D.-S.; Chen P.-J.; Hsu P.-N.; Yang S.-S.; Kao J.-H.
臺大學術典藏	2021-06-15T03:12:11Z	Reduced toll-like receptor 9 expression on peripheral C D14+ monocytes of chronic hepatitis B patients and its restoration by effective therapy	Huang Y.-W.; Hsu C.-K.; Lin S.-C.; SHU-CHEN WEI; Hu J.-T.; Chang H.-Y.; Liang C.-W.; Chen D.-S.; Chen P.-J.; Hsu P.-N.; Yang S.-S.; Kao J.-H.
臺大學術典藏	2021-06-03T06:50:15Z	Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition	Su T.-H.;Shiau C.-W.;Jao P.;Liu C.-H.;Liu C.-J.;Tai W.-T.;Jeng Y.-M.;Yang H.-C.;Tseng T.-C.;Hsiang-Po Huang;Cheng H.-R.;Chen P.-J.;Chen K.-F.;Kao J.-H.;Chen D.-S.; Su T.-H.; Shiau C.-W.; Jao P.; Liu C.-H.; Liu C.-J.; Tai W.-T.; Jeng Y.-M.; Yang H.-C.; Tseng T.-C.; HSIANG-PO HUANG; Cheng H.-R.; Chen P.-J.; Chen K.-F.; Kao J.-H.; Chen D.-S.
臺大學術典藏	2021-05-27T09:07:07Z	Influence of hepatitis C virus infection on soluble cellular adhesion molecules in hemodialysis patients	Peng Y.-S.;Chih-Kang Chiang;Hsu S.-P.;Pai M.-F.;Hung K.-Y.;Kao J.-H.; Peng Y.-S.; CHIH-KANG CHIANG; Hsu S.-P.; Pai M.-F.; Hung K.-Y.; Kao J.-H.
臺大學術典藏	2021-05-27T09:06:54Z	Association of hepatitis C virus infection and malnutrition-inflammation complex syndrome in maintenance hemodialysis patients	Tsai H.-B.;Chen P.-C.;Liu C.-H.;Hung P.-H.;Chen M.-T.;Chih-Kang Chiang ;Kao J.-H.;Hung K.-Y.; Tsai H.-B.; Chen P.-C.; Liu C.-H.; Hung P.-H.; Chen M.-T.; CHIH-KANG CHIANG; Kao J.-H.; Hung K.-Y.
臺大學術典藏	2021-05-27T08:20:46Z	Distinct Relapse Rates and Risk Predictors after Discontinuing Tenofovir and Entecavir Therapy	Su T.-H.; Yang H.-C.; Tseng T.-C.; JYH-MING LIOU; Liu C.-H.; Chen C.-L.; Chen P.-J.; Chen D.-S.; Liu C.-J.; Kao J.-H.
臺大學術典藏	2021-05-26T03:35:07Z	Paratyphoid hepatitis: An emerging clinical entity [5]	Hsueh P.-R.; Kao J.-H.; Chen Y.-C.; Yang P.-C.; KWEN-TAY LUH; Wang T.-K.; Lin S.-F.
臺大學術典藏	2021-05-24T07:20:59Z	Selective transmission of hepatitis C virus quasi species through a needlestick accident in acute resolving hepatitis	CHEN-HUA LIU; Chen B.-F.; Chen S.-C.; Lai M.-Y.; Kao J.-H.; Chen D.-S.
臺大學術典藏	2021-05-24T07:20:59Z	Noninvasive tests for the prediction of significant hepatic fibrosis in hepatitis C virus carriers with persistently normal alanine aminotransferases	CHEN-HUA LIU; Lin J.-W.; Tsai F.-C.; Yang P.-M.; Lai M.-Y.; Chen J.-H.; Kao J.-H.; Chen D.-S.
臺大學術典藏	2021-05-24T07:20:57Z	Interferon-based therapy for dialysis patients with chronic hepatitis C: Progress and challenges	CHEN-HUA LIU; Liu C.-J.; Kao J.-H.
臺大學術典藏	2021-05-24T07:20:57Z	Association of pre-S deletion mutant of hepatitis B virus with risk of hepatocellular carcinoma	Lin C.-L.; CHEN-HUA LIU; Chen W.; Huang W.-L.; Chen P.-J.; Lai M.-Y.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-05-24T07:20:56Z	Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV [6]	CHEN-HUA LIU; Chen D.-S.; Kao J.-H.

顯示項目 626-650 / 1534 (共62頁)
<< < 21 22 23 24 25 26 27 28 29 30 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :2856565
	造訪人次 : 53374732 線上人數 : 1388 教育部委託研究計畫計畫執行:國立臺灣大學圖書館